Performance of a multi-cancer early detection test in the randomized controlled NHS-Galleri trial
Nature Medicine, Published online: 22 September 2026; doi:10.1038/s41591-026-04652-8 Secondary endpoint analyses in the NHS-Galleri randomized controlled trial, testing a multi-cancer early detection test added to usual care, provide insights on the performance of the blood-based test in more than 142,000 participants without suspicion of cancer.
We haven't written up this one. Nature Medicine has the full story — the link below goes straight to it.
